Vertex Pharmaceuticals Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Company Highlights
Year Founded

1989

icon-altEmployees

6,103

Location (HQ)

USA

Since Last Funding

4 months

Monthly Website Visitors

346.3K

icon-altTotal Investment Amt

$700M

Last Funding Round

Post Ipo Secondary

icon-altMoM Headcount Growth

0.71%

icon-altYoY Headcount Growth

7.13%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Medical

Biotechnology Research

Pharmaceutical